Moderna will begin producing a retooled model of its coronavirus vaccine within the Netherlands, doubling the corporate’s anticipated EU manufacturing, the corporate introduced right now.
The brand new contract, inked with the subcontractor Lonza, will permit Moderna to make roughly 300 million doses a 12 months beginning on the finish of 2021. The Dutch web site, along with a drug-substance web site run by Rovi in Spain, will permit Moderna to make 600 million doses a 12 months within the EU.
At the moment, the American firm would not make any drug substance within the EU. As a substitute, it has outsourced its vaccine substance manufacturing to Lonza’s web site in Switzerland to provide the EU, U.Okay. and Canada. However manufacturing points there compelled the corporate to chop projected deliveries to the U.Okay. and Canada earlier this 12 months.
The corporate provided 10 million doses to the EU on the finish of March, and is predicted to provide 35 million doses by the tip of June.
Moderna’s anticipated 600 million dose estimate is predicated on whether or not its retooled vaccine requires 50 micrograms of drug substance per dose and is authorized by the regulators. The corporate is trialing retooled variations of its vaccine, which has been authorized within the EU since early January.